George Soros’s Amicus Therapeutics FOLD Stock Holding History

George Soros’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,753,186	Closed	-$83.2M	–	292
2026 Q1	$83.2M	Buy	5,753,186 +753,186	+15%	+$10.8M	0.91%	26
2025 Q4	$71.2M	Buy	+5,000,000	New	+$49.1M	0.82%	42
2014 Q3	–	Sell	-70,500	Closed	-$235K	–	288
2014 Q2	$235K	Buy	+70,500	New	+$165K	﹤0.01%	293

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

George Soros's FOLD Position: Q2 2026 in Review

George Soros sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 5,753,186 shares — an estimated $83.2M sold.

George Soros first reported a position in FOLD in Q2 2014 and held it in 3 quarters. The position peaked at $83.2M in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

George Soros reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
George Soros sold 5,753,186 Amicus Therapeutics shares in Q2 2026, an estimated $83.2M.
George Soros first reported a position in Amicus Therapeutics in Q2 2014 and held it in 3 quarters.
George Soros's Amicus Therapeutics position peaked at $83.2M in Q1 2026.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Soros Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.